|
PHF10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.612700E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.464500E-02 |
| Normal-vs-Stage2 |
9.572200E-02 |
| Normal-vs-Stage3 |
1.353140E-04 |
| Normal-vs-Stage4 |
5.59119999999913E-05 |
| Stage1-vs-Stage2 |
6.251800E-01 |
| Stage1-vs-Stage3 |
1.578210E-02 |
| Stage1-vs-Stage4 |
9.758600E-03 |
| Stage2-vs-Stage3 |
3.473000E-01 |
| Stage2-vs-Stage4 |
2.201800E-01 |
| Stage3-vs-Stage4 |
6.202400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.373500E-04 |
| Normal-vs-AfricanAmerican |
1.069400E-01 |
| Normal-vs-Asian |
1.252380E-01 |
| Caucasian-vs-AfricanAmerican |
4.901000E-01 |
| Caucasian-vs-Asian |
8.384400E-01 |
| AfricanAmerican-vs-Asian |
6.588800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.423000E-04 |
| Normal-vs-Female |
1.293920E-02 |
| Male-vs-Female |
2.718200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.399500E-03 |
| Normal-vs-Age(41-60Yrs) |
7.236900E-03 |
| Normal-vs-Age(61-80Yrs) |
9.844100E-04 |
| Normal-vs-Age(81-100Yrs) |
4.122400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.525800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.504400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.622200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.250400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.555200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.457400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.700200E-02 |
| Normal-vs-Grade 2 |
5.318200E-01 |
| Normal-vs-Grade 3 |
3.36840000003669E-07 |
| Normal-vs-Grade 4 |
3.48049999931987E-08 |
| Grade 1-vs-Grade 2 |
7.049900E-02 |
| Grade 1-vs-Grade 3 |
1.55413999999299E-05 |
| Grade 1-vs-Grade 4 |
2.28140000002597E-06 |
| Grade 2-vs-Grade 3 |
9.20339999765929E-08 |
| Grade 2-vs-Grade 4 |
5.71049999509299E-08 |
| Grade 3-vs-Grade 4 |
1.167790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.728400E-01 |
| Normal-vs-ccB subtype |
7.22979999978612E-07 |
| ccA subtype-vs-ccB subtype |
1.14849999999223E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.301500E-03 |
| Normal-vs-N1 |
2.185700E-04 |
| N0-vs-N1 |
6.062000E-02 |
|
|
